CVS Health shares climbed Tuesday after the health conglomerate raised its full-year outlook and outlined plans for a new AI ...

CVS unveils AI platform raises 2025 forecast, projecting $400B revenue and improved earnings to enhance consumer healthcare experience.

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

CVS Health shared that it is launching an open consumer engagement platform to simplify care and improve health.

It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 ...

CVS Health used its Investor Day on Tuesday as a megaphone for the retailer’s success, raising its full-year financial ...

CVS Health’s stock rose more than 2% on Tuesday after the company boosted its revenue and profit guidance for the year and ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insurance, pharmacy benefit management, and retail ...

In addition to the updates for 2025, CVS offered its first look at expected earnings for 2026. The company said it ...